Clearside Biomedical, Inc(NASDAQ:CLSD) 
Clearside Biomedical, Inc., a biopharmaceutical company, engages in the developing and delivering treatments that restore and preserve vision for people with serious eye diseases. Its product includes CLS-AX, an axitinib for suprachoroidal injection which is in Phase 1/2a clinical trial. It also dev...
Website: http://www.clearsidebio.com
Founded: 2011
Full Time Employees: 33
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 12.89
H 13.49
L 12.59
C 12.89
V 155,937
10EMA 12.89
20EMA 12.89
60EMA 12.89
120EMA 12.89
250EMA 12.89